Thrombocytopenia
269 results
201 - 269
Transfusion thresholds for guiding allogeneic red blood cell transfusion - Adder (Vipera berus) bite
- Myelodysplastic syndromes (MDS)
Treatment of newly diagnosed glioblastoma in the elderly: a network meta‐analysis- Prophylaxis of thromboembolism during therapy with asparaginase in adults with acute lymphoblastic leukaemia
- Anticoagulants for people hospitalised with COVID‐19
- Gemcitabine‐based chemotherapy for advanced biliary tract carcinomas
- Anticoagulation for the long‐term treatment of venous thromboembolism in people with cancer
- Peginterferon plus ribavirin versus interferon plus ribavirin for chronic hepatitis C
- Heparin-bonded catheters for prolonging the patency of central venous catheters in children: Cochrane systematic review
- Pharmacological interventions for preventing venous thromboembolism in people undergoing bariatric surgery
- Anticoagulation for the long term treatment of venous thromboembolism in patients with cancer
- Viral diseases in warm climates
- Prevention of venous thromboembolism
- Interventions for atypical haemolytic uraemic syndrome
- Comparison of first‐line chemotherapy including escalated BEACOPP versus chemotherapy including ABVD for people with early unfavourable or advanced stage Hodgkin lymphoma
- Erythropoietin or darbepoetin for patients with cancer
- Aspirin or heparin or both for improving pregnancy outcomes in women with persistent antiphospholipid antibodies and recurrent pregnancy loss
- Hydroxyurea for reducing blood transfusion in non‐transfusion dependent beta thalassaemias
- Linezolid versus vancomycin for skin and soft tissue infections
- Thrombopoietin mimetics for patients with myelodysplastic syndromes: Cochrane systematic review
- Evaluation of thrombophilia
- Indications for and implementation of anticoagulant therapy in atrial fibrillation
- Low molecular weight heparins for acute coronary syndromes
- Susceptibility to infections in adults
- Cooling for newborns with hypoxic ischaemic encephalopathy
- Systemic lupus erythematosus (SLE)
- Bacterial diseases in warm climates
- Recurrent infections and immunodeficiencies in children
- Acute leukaemias in adults
- Mycophenolic acid for kidney transplant recipients
- Interleukin 2 receptor antagonists for kidney transplant recipients: Cochrane systematic review
- Heparin for assisted reproduction
- Early introduction of lipids to parenterally‐fed preterm infants
- Leucopenia
- Peptic ulcer disease, Helicobacter pylori infection and chronic gastritis
- Safety of non-steroidal anti-inflammatory drugs, including aspirin and paracetamol (acetaminophen) in people receiving methotrexate for inflammatory arthritis (rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, other spondyloarthritis): Cochrane systematic review
- Mycophenolic acid versus azathioprine as primary immunosuppression for kidney transplant recipients
- Parenteral anticoagulation in ambulatory patients with cancer
- Quinine for muscle cramps
- Interleukin‐2 as maintenance therapy for children and adults with acute myeloid leukaemia in first complete remission
- Bortezomib for the treatment of multiple myeloma: Cochrane systematic review
- Interferon alpha for chronic hepatitis D
- Rituximab, ofatumumab and other monoclonal anti-CD20 antibodies for chronic lymphocytic leukaemia: Cochrane systematic review
- Anti‐epidermal growth factor receptor therapy for glioblastoma in adults
- Best first‐line therapy for people with advanced non‐small cell lung cancer, performance status 2 without a targetable mutation or with an unknown mutation status
- Lower leg dermatitis
- Platinum‐based chemotherapy for early triple‐negative breast cancer
- Pentasaccharides for the treatment of deep vein thrombosis
- Antifibrinolytics (lysine analogues) for the prevention of bleeding in people with haematological disorders: Cochrane systematic review
- Aerobic physical exercise for adult patients with haematological malignancies
- Transfusion thresholds for guiding red blood cell transfusion
- Alternatives, and adjuncts, to prophylactic platelet transfusion for people with haematological malignancies undergoing intensive chemotherapy or stem cell transplantation
- Cyclophosphamide for connective tissue disease–associated interstitial lung disease
- Linezolid for drug‐resistant pulmonary tuberculosis
- Pentasaccharides for the prevention of venous thromboembolism: Cochrane systematic review
- Foetal haemoglobin inducers for reducing blood transfusion in non‐transfusion‐dependent beta‐thalassaemias
- Acute coronary syndrome
- Postinfectious syndromes
- Deep vein thrombosis
- Exanthem (eruptive skin rash)